| pubmed-article:10972484 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10972484 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:10972484 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:10972484 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:10972484 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:10972484 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10972484 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:10972484 | lifeskim:mentions | umls-concept:C1720851 | lld:lifeskim |
| pubmed-article:10972484 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10972484 | pubmed:dateCreated | 2000-9-25 | lld:pubmed |
| pubmed-article:10972484 | pubmed:abstractText | Cryptophycins are a family of antitubulin antitumor agents. A synthetic cryptophycin derivative (LY355703, CRYPTO 52) is in early clinical evaluation. The effect of infusion time on the antitumor activity of four cryptophycins was assessed in rats bearing the 13762 mammary carcinoma and combination treatment regimens were assessed in nude mice bearing human tumor xenografts. | lld:pubmed |
| pubmed-article:10972484 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10972484 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10972484 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10972484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10972484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10972484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10972484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10972484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10972484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10972484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10972484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10972484 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10972484 | pubmed:issn | 0344-5704 | lld:pubmed |
| pubmed-article:10972484 | pubmed:author | pubmed-author:AlvarezEE | lld:pubmed |
| pubmed-article:10972484 | pubmed:author | pubmed-author:ShinMM | lld:pubmed |
| pubmed-article:10972484 | pubmed:author | pubmed-author:TeicherB ABA | lld:pubmed |
| pubmed-article:10972484 | pubmed:author | pubmed-author:MenonKK | lld:pubmed |
| pubmed-article:10972484 | pubmed:author | pubmed-author:PharesVV | lld:pubmed |
| pubmed-article:10972484 | pubmed:author | pubmed-author:AmsrudTT | lld:pubmed |
| pubmed-article:10972484 | pubmed:author | pubmed-author:ForlerPP | lld:pubmed |
| pubmed-article:10972484 | pubmed:author | pubmed-author:Al-AwarRR | lld:pubmed |
| pubmed-article:10972484 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10972484 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:10972484 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10972484 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10972484 | pubmed:pagination | 142-9 | lld:pubmed |
| pubmed-article:10972484 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:meshHeading | pubmed-meshheading:10972484... | lld:pubmed |
| pubmed-article:10972484 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10972484 | pubmed:articleTitle | Antitumor activity of cryptophycins: effect of infusion time and combination studies. | lld:pubmed |
| pubmed-article:10972484 | pubmed:affiliation | Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA. | lld:pubmed |
| pubmed-article:10972484 | pubmed:publicationType | Journal Article | lld:pubmed |
